JDD Corner

JDD Buzz Series | DermTok: Who’s Talking Sun?
sun protectionTikTok is a source of beauty and skin health information for the masses. Yet much of the content is not produced by board-certified dermatologists or even other healthcare professionals. So who’s creating TikTok content about sun protection and skin cancer? Does any of this content address skin of color? Those are the questions a new cross-sectional analysis published in the July Journal of Drug …
sun protection
JDD August 2024 Issue Highlights
PSORIASIS In the August edition of the Journal of Drugs in Dermatology (JDD), we turn our focus to psoriasis, one of the most challenging and impactful dermatological conditions. This month’s Editor's Picks showcase a series of in-depth studies and expert discussions that explore the latest advancements in psoriasis treatment, real-world effectiveness, and the broader implications of the disease …
PSORIASIS
Racial and Ethnic Diversity in Vitiligo Clinical Trials
clinical trialsOur latest blog post explores the study "Racial and Ethnic Diversity in Vitiligo Clinical Trials: A Retrospective Cross-Sectional Study Assessing Demographic Reporting of Participants" published in the Journal of Drugs in Dermatology by Holla et al. Key Findings: Significant gaps in demographic reporting. Underrepresentation of non-White participants. The need for inclusive res …
clinical trials
A Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery
wound closure Wound repair of the pretibial and forearm regions presents a challenge during dermatologic surgery as these areas are under significant tension and exhibit increased skin fragility. Various methodologies have been proposed for the closure and repair of such wounds, however, the use of the bilayered suture technique may be simpler and more effective than other techniques such as the pinch stitc …
wound closure
Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit
basal cell carcinomaINTRODUCTION Periocular basal cell carcinoma (BCC) is the most common eyelid malignancy concomitant with ocular morbidity and quality of life impact.1,2 Orbital invasion occurs in 2% of cases and poses challenges for management.1,3 JDD authors highlight a multidisciplinary approach to the treatment of advanced periocular BCC.   CASE JDD authors discuss a 56-year-old male who presente …
basal cell carcinoma